An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors

被引：26
作者：
Mohebbi, Alireza [1 ,2 ]
Lorestani, Nazanin [1 ]
Tahamtan, Alireza [2 ]
Kargar, Niki L. [1 ]
Tabarraei, Alijan [2 ,3 ]
机构：
[1] Golestan Univ Med Sci, Sch Med, Student Res Comm, Gorgan, Iran
[2] Golestan Univ Med Sci, Sch Med, Dept Microbiol, Gorgan, Iran
[3] Golestan Univ Med Sci, Infect Dis Res Ctr, Gorgan, Iran
来源：
FRONTIERS IN MICROBIOLOGY | 2018年 / 9卷
关键词：
hepatitis B virus; chronic hepatitis B virus infection; HBsAg inhibitors; anti-viral natural products; RNA interference; REVERSE-TRANSCRIPTASE SEQUENCES; DRUG-RESISTANCE MUTATIONS; SERUM HBV DNA; NF-KAPPA-B; IN-VIVO; NAIVE; REPLICATION; ENTRY; DERIVATIVES; MICE;
D O I：
10.3389/fmicb.2018.00662
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Current anti-hepatitis B virus (HBV) regimen do not meet ideal result due to emerging resistance strains, cytotoxicity, and unfavorable adverse effects. In chronic HBV infection, high rates of sub-viral particles (SVPs) bearing HBV surface antigen (HBsAg) is a major obstacle regarding to raise effective immune responses and subsequently virus clearance. Development of potent HBsAg secretion inhibitors would provide a better insight into HBV immunopathogenesis and therapy. Investigating new non-toxic HBsAg secretion inhibitors targeting either viral or cellular factors could restore the immune response to remove virally infected hepatocytes after inhibiting SVPs. In this study, we overview several classes of HBV inhibitors with focus on their limitations and advantages over anti-HBsAg secretion potential.
引用
收藏
页数：9
相关论文
共 70 条
  • [1] The Role of cccDNA in HBV Maintenance
    Allweiss, Lena
    Dandri, Maura
    [J]. VIRUSES-BASEL, 2017, 9 (06):
  • [2] The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics
    Blank, A.
    Eidam, A.
    Haag, M.
    Hohmann, N.
    Burhenne, J.
    Schwab, M.
    van de Graaf, S. F. J.
    Meyer, M. R.
    Maurer, H. H.
    Meier, K.
    Weiss, J.
    Bruckner, T.
    Alexandrov, A.
    Urban, S.
    Mikus, G.
    Haefeli, W. E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 341 - 348
  • [3] First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
    Blank, Antje
    Markert, Christoph
    Hohmann, Nicolas
    Carls, Alexandra
    Mikus, Gerd
    Lehr, Thorsten
    Alexandrov, Alexander
    Haag, Mathias
    Schwab, Matthias
    Urban, Stephan
    Haefeli, Walter E.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 483 - 489
  • [4] TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
    Boni, Carolina
    Vecchi, Andrea
    Rossi, Marzia
    Laccabue, Diletta
    Giuberti, Tiziana
    Alfieri, Arianna
    Lampertico, Pietro
    Grossi, Glenda
    Facchetti, Floriana
    Brunetto, Maurizia R.
    Coco, Barbara
    Cavallone, Daniela
    Mangia, Alessandra
    Santoro, Rosanna
    Piazzolla, Valeria
    Lau, Audrey
    Gaggar, Anuj
    Subramanian, G. Mani
    Ferrari, Carlo
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : 1764 - +
  • [5] A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice
    Cai, Xiaodan
    Zheng, Weihao
    Pan, Shaokun
    Zhang, Shengyuan
    Xie, Youhua
    Guo, Haitao
    Wang, Guoxin
    Li, Zigang
    Luo, Ming
    [J]. ANTIVIRAL RESEARCH, 2018, 149 : 48 - 57
  • [6] No cure for hepatitis B and D without targeting integrated viral DNA?
    Cornberg, Markus
    Manns, Michael P.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (04) : 195 - 196
  • [7] Luteolin-7-O-Glucoside Present in Lettuce Extracts Inhibits Hepatitis B Surface Antigen Production and Viral Replication by Human Hepatoma Cells in Vitro
    Cui, Xiao-Xian
    Yang, Xiao
    Wang, Hui-Jing
    Rong, Xing-Yu
    Jing, Sha
    Xie, You-Hua
    Huang, Dan-Feng
    Zhao, Chao
    [J]. FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [8] Cyclophilin A: A Key Factor in Virus Replication and Potential Target for Anti-viral Therapy
    Dawar, Farman Ullah
    Tu, Jiagang
    Khattak, Muhammad Nasir Khan
    Mei, Jie
    Lin, Li
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2017, 21 : 1 - 20
  • [9] A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion
    Dougherty, Anne Marie
    Guo, Haitao
    Westby, Gael
    Liu, Yuanjie
    Simsek, Ender
    Guo, Ju-Tao
    Mehta, Anand
    Norton, Pamela
    Gu, Baohua
    Block, Timothy
    Cuconati, Andrea
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) : 4427 - 4437
  • [10] El Rashedy AA, 2013, MINI-REV MED CHEM, V13, P399
1234567